General
Preferred name
NMN
Synonyms
¦Â-NM ()
β-NM ()
??Nicotinamide mononucleotide ()
??NM ()
Nicotinamide Mononucleotide ()
β-Nicotinamide mononucleotide ()
¦Â-Nicotinamide Mononucleotide ()
¦Â-NM, NMN ()
??-Nicotinamide Mononucleotide ()
BETANMN ()
.beta.-Nicotinamide Mononucleotide ()
P&D ID
PD017919
CAS
1094-61-7
Tags
available
drug candidate
Drug indication
Dietary shortage
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
35
DESCRIPTION
??-nicotinamide mononucleotide (NMN) is a natural nucleotide and a key intermediate in the synthesis of coenzyme I (NAD+). ??-nicotinamide mononucleotide is involved in a number of biochemical reactions in the human body, which are related to immunity and metabolism.
DESCRIPTION
β-nicotinamide mononucleotide (NMN) is a natural nucleotide and a key intermediate in the synthesis of coenzyme I (NAD+). β-nicotinamide mononucleotide is involved in a number of biochemical reactions in the human body, which are related to immunity and metabolism.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
4
Cayman Chemical Bioactives
DrugMAP
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
33
Molecular Weight
334.06
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
4
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
1
cLogP
-2.83
TPSA
166.25
Fraction CSP3
0.45
Chiral centers
5.0
Largest ring
6.0
QED
0.33
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Therapeutic Class
Bone Density Conservation Agents
Pathway
Metabolism
Source data

